Skip to content

Effect of Test Chewing Gums on bad breath and oral micro-organisms

Effect of Test Chewing Gums on Oral Malodour and Oral Pathogens

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/04/004519
Enrollment
78
Registered
2014-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Product 1 - Chewing Gum PCG : Gums must be consumed thrice a day after meals for 15 vdays Intervention2: Product 2 - Chewing Gum PCG: Gums must be consumed thrice a day after meals for

Sponsors

ITC Limited
Lead Sponsor
Karmic Lifesciences
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males and females, more than or equal to 18 years to less than or equal to 50 years of age 2. Halimeter reading of T-VSC (total volatile sulphur compounds) of 200 ppb (parts per billion) or more 3. Salivary levels of S. mutans more than 10,000 CFU/mL 4. Subjects with non-compromised oral health â?? Subjects should not have untreated caries lesions, clinical signs of gingivitis or periodontal disease, orthodontic patients, oral carcinoma, etc. 5. Subjects not undergoing antibiotic or antimicrobial therapy 6. Subjects willing to use standard toothpaste and toothbrush provided to them, throughout the study 7. Subjects willing to use a tongue cleaner provided to them, throughout the study 8. Females of child-bearing potential and males should be willing to use adequate methods of contraception 9. Must be willing and able to give informed consent and comply with the study procedures.

Exclusion criteria

Exclusion criteria: 1. Subjects using fixed orthodontic appliances 2. Subjects on drugs for xerostomia, e.g. pilocarpine or cevimeline 3. Subjects who are allergic to any of the ingredients of the study product 4. Subjects who have undergone long term antibiotic therapy (for 30 days or more in the past three months) 5. Subjects who are smokers or current users of narcotics 6. Subjects using commercial mouthwash, antibacterial tooth paste and dental floss 7. Subjects who are consuming probiotics products in any formats 8. Pregnant or lactating women 9. Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study

Design outcomes

Primary

MeasureTime frame
Effect assessed in terms of mean reduction in halimeter readings of T-VSC (total volatile sulphur compounds) between the groupsTimepoint: From baseline, Day 1 to Day 15

Secondary

MeasureTime frame
Improvement in QOL affected by oral malodourTimepoint: From baseline, Day 1 to Day 15 and Day 21;Improvement in subject-satisfaction after using the investigational products.Timepoint: From baseline, Day 1 to Day 15 and Day 21;Increase in salivary counts of Lactobacilli sp.Timepoint: From baseline, Day 1 to Day 15 and Day 2;Mean reduction in halimeter readings of T-VSC between the groupsTimepoint: From baseline, Day 1 to Day 21;Mean reduction in organoleptic measurements between the groupsTimepoint: From baseline, Day 1 to Day 15 and Day 21;Reduction in counts of C.albicans between the groupsTimepoint: From baseline, Day 1 to Day 15 and Day 21;Reduction in counts of P.gingivalis between the groupsTimepoint: From baseline, Day 1 to Day 15 and Day 21;Reduction in counts of S. mutans between the groupsTimepoint: From baseline, Day 1 to Day 15 and Day 21

Countries

India

Contacts

Public ContactDr Simran Sethi

V S Dental College & Hospital

shamagl@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026